Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Chan

Showing results (141-150 of 195) with videos related to

Pageof 20
Sort By:
Clinical Laboratory|February 21, 2003
Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patientsPetra Stieber, Rafael Molina, Daniel W Chan, et al.
Proteomics|July 30, 2005
HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samplesAlex J Rai, Craig A Gelfand, Bruce C Haywood, et al.
Cell Reports|October 21, 2020
Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian CarcinomaYingwei Hu, Jianbo Pan, Punit Shah, et al.
Journal of Proteomics|August 1, 2012
Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay testsTao Liu, Mahmud Hossain, Athena A Schepmoes, et al.
JU Open Plus|February 19, 2026
Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate CancerNicholas W Eyrich, Yijian Huang, Yingye Zheng, et al.
Urologic Oncology|April 20, 2020
Development and evaluation of the MiCheck test for aggressive prostate cancerNeal D Shore, Christopher M Pieczonka, R Jonathan Henderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?John T Wei, Ziding Feng, Alan W Partin, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsyStefan E Eng, Benjamin Basasie, Alfonso Lam, et al.
The Journal of Urology|December 3, 2014
The prostate health index selectively identifies clinically significant prostate cancerStacy Loeb, Martin G Sanda, Dennis L Broyles, et al.
Journal of Proteome Research|May 30, 2012
Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategiesAmol Prakash, Taha Rezai, Bryan Krastins, et al.
Pageof 20

Showing results (141-150 of 195) with videos related to

Sort By:
Pageof 20
Clinical Laboratory|February 21, 2003
Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patientsPetra Stieber, Rafael Molina, Daniel W Chan, et al.
Proteomics|July 30, 2005
HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samplesAlex J Rai, Craig A Gelfand, Bruce C Haywood, et al.
Cell Reports|October 21, 2020
Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian CarcinomaYingwei Hu, Jianbo Pan, Punit Shah, et al.
Journal of Proteomics|August 1, 2012
Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay testsTao Liu, Mahmud Hossain, Athena A Schepmoes, et al.
JU Open Plus|February 19, 2026
Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate CancerNicholas W Eyrich, Yijian Huang, Yingye Zheng, et al.
Urologic Oncology|April 20, 2020
Development and evaluation of the MiCheck test for aggressive prostate cancerNeal D Shore, Christopher M Pieczonka, R Jonathan Henderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?John T Wei, Ziding Feng, Alan W Partin, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsyStefan E Eng, Benjamin Basasie, Alfonso Lam, et al.
The Journal of Urology|December 3, 2014
The prostate health index selectively identifies clinically significant prostate cancerStacy Loeb, Martin G Sanda, Dennis L Broyles, et al.
Journal of Proteome Research|May 30, 2012
Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategiesAmol Prakash, Taha Rezai, Bryan Krastins, et al.
Pageof 20